Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience, Artisan Development Labs Collaborate on Antibody Discovery, Cell Therapies

NEW YORK – Twist Bioscience said on Tuesday that it is collaborating with Artisan Development Labs (Artisan Bio) to discover novel antibodies against five undisclosed targets.

Under the terms of the collaboration, Twist will apply its proprietary Library of Libraries to discover novel antibodies directed against Artisan Bio's immunotherapy targets. Artisan will leverage its Immune Cell Engineering Foundry and STAR Guides to develop custom cell therapeutics. Twist will receive upfront technology access and project fees for each program; success-based clinical, regulatory, and commercial milestones; and royalties on product sales.

The deal includes an option for additional targets. Other details were not disclosed.

"Artisan has a unique approach that combines a deep understanding of this gene-editing technology with advanced AI analysis," Twist cofounder and CEO Emily Leproust said in a statement. "Our collaboration with Artisan will leverage our innovative antibody discovery capabilities to help translate this cutting-edge approach into novel cell therapies."

Artisan Bio has operations in Denver; Copenhagen, Denmark; and Toronto. According to its website, it has received investment from XSeed Capital, Northpond Ventures, and Takeda Ventures.

Twist continues to build partnerships around antibody discovery. Last year it signed such deals with Pure Biologics, Adicet Bio, and Boehringer Ingelheim.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.